4
11
Ṁ40Ṁ330
2027
33%
chance
1D
1W
1M
ALL
Resolves YES if the FDA grants full approval for the commercial sale of any mRNA vaccine against esophageal adenocarcinoma in the United States before January 1, 2028. This does not include emergency use authorization or other forms of limited authorization. Resolves NO otherwise.
Get Ṁ600 play money
More related questions
Related questions
Will FDA approve any mRNA vaccine against melanoma before 2028?
49% chance
Will FDA approve any mRNA vaccine against non-small-cell lung carcinoma before 2028?
38% chance
Will FDA approve any mRNA vaccine against colorectal adenocarcinoma before 2028?
30% chance
Will FDA approve any mRNA vaccine against malaria before 2028?
45% chance
Will FDA approve any mRNA vaccine against squamous cell carcinoma before 2028?
35% chance
Will FDA approve any mRNA vaccine against any type of herpes simplex infection before 2028?
63% chance
Will FDA approve any mRNA vaccine against stomach adenocarcinoma before 2028?
24% chance
Will FDA approve any mRNA vaccine against pancreatic adenocarcinoma before 2028?
19% chance
Will FDA approve any mRNA vaccine against prostate adenocarcinoma before 2028?
41% chance
Will FDA approve any mRNA vaccine against any type of breast cancer before 2028?
29% chance